483
Catalent Maryland IncCatalent Maryland Inc – FDA 483, Nov 17, 2021
Record Details
Catalent Maryland, Inc. in Harmans, MD, a manufacturer of gene therapy and vaccine drug substance, was cited for significant deficiencies during an FDA inspection. Observations included manufacturing outside validated ranges, inadequate contamination controls for new products, insufficient quality oversight for investigations and inventory, deficient sample analysis procedures, and inadequate environmental monitoring. The firm also had incomplete investigations and insufficient storage space.
View Company Profile
ID · 3d25d720-4dc4-450c-a351-5d2f1516da0e
Other documents for Catalent Maryland Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.